Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose-volume metric-based prediction of radiotherapy-induced lymphocyte loss in patients with non-small-cell lung cancer treated with modern radiotherapy techniques.
Nowicka Z, Kuna K, Łaszczych M, Łazar-Poniatowska M, Sobocki BK, Stawiski K, Dąbrowski M, Bruski K, Zięba A, Pajdziński M, Staniewska E, Miszczyk M, Paganetti H, Fendler W, Tomasik B. Nowicka Z, et al. Among authors: miszczyk m. Phys Imaging Radiat Oncol. 2024 May 27;30:100593. doi: 10.1016/j.phro.2024.100593. eCollection 2024 Apr. Phys Imaging Radiat Oncol. 2024. PMID: 38912008 Free PMC article.
Volumetric staging in radiotherapy for oropharyngeal cancers.
Miszczyk M, Staniewska E, Jabłońska I, Lipka-Rajwa A, Stawiski K, Tarnawski R. Miszczyk M, et al. Tumori. 2022 Dec;108(6):586-591. doi: 10.1177/03008916211050959. Epub 2021 Oct 9. Tumori. 2022. PMID: 34628998
The prognostic value of red cell distribution width (RDW), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) in radiotherapy for oropharyngeal cancer.
Staniewska E, Tomasik B, Tarnawski R, Łaszczych M, Miszczyk M. Staniewska E, et al. Among authors: miszczyk m. Rep Pract Oncol Radiother. 2021 Dec 30;26(6):1010-1018. doi: 10.5603/RPOR.a2021.0126. eCollection 2021. Rep Pract Oncol Radiother. 2021. PMID: 34992875 Free PMC article.
Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancer.
Miszczyk M, Magrowski Ł, Masri O, Jabłon'ska I, Nowicka Z, Krzysztofiak T, Wojcieszek P, Lipka-Rajwa A, Ciepał J, Depowska G, Chimiak K, Bylica G, Płoszka K, Łaszczych M, Majewski W. Miszczyk M, et al. J Contemp Brachytherapy. 2022 Feb;14(1):15-22. doi: 10.5114/jcb.2022.113546. Epub 2022 Feb 18. J Contemp Brachytherapy. 2022. PMID: 35233230 Free PMC article.
The Prognostic Value of PI-RADS Score in CyberKnife Ultra-Hypofractionated Radiotherapy for Localized Prostate Cancer.
Miszczyk M, Rembak-Szynkiewicz J, Magrowski Ł, Stawiski K, Namysł-Kaletka A, Napieralska A, Kraszkiewicz M, Woźniak G, Stąpór-Fudzińska M, Głowacki G, Pradere B, Laukhtina E, Rajwa P, Majewski W. Miszczyk M, et al. Cancers (Basel). 2022 Mar 23;14(7):1613. doi: 10.3390/cancers14071613. Cancers (Basel). 2022. PMID: 35406385 Free PMC article.
Conventionally fractionated radiotherapy versus CyberKnife hypofractionated radiotherapy for painful vertebral haemangiomas - A randomized clinical trial.
Miszczyk M, Napieralska A, Woźniak G, Kraszkiewicz M, Gola M, Kalemba M, Głowacki G, Tomasik B, Kocot-Kępska M, Miszczyk L. Miszczyk M, et al. Among authors: miszczyk l. Radiother Oncol. 2022 Nov;176:46-52. doi: 10.1016/j.radonc.2022.09.008. Epub 2022 Sep 19. Radiother Oncol. 2022. PMID: 36184997 Clinical Trial.
Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological Risk.
Miszczyk M, Szołtysik M, Hasterok M, Goldner G, Rajwa P, Namysł-Kaletka A, Napieralska A, Kraszkiewicz M, Stąpór-Fudzińska M, Tomasik B, Woźniak G, Głowacki G, Kaminiów K, Moll M, Magrowski Ł, Majewski W. Miszczyk M, et al. Biomedicines. 2022 Sep 30;10(10):2446. doi: 10.3390/biomedicines10102446. Biomedicines. 2022. PMID: 36289708 Free PMC article.
Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing Radiotherapy.
Magrowski Ł, Masri O, Ciepał J, Depowska G, Nowicka Z, Stando R, Chimiak K, Bylica G, Czapla B, Masri M, Cichur F, Jabłońska I, Gmerek M, Wojcieszek P, Krzysztofiak T, Sadowski J, Suwiński R, Rajwa P, Moll M, Goldner G, Majewski W, Miszczyk M. Magrowski Ł, et al. Among authors: miszczyk m. Biomedicines. 2022 Oct 8;10(10):2514. doi: 10.3390/biomedicines10102514. Biomedicines. 2022. PMID: 36289778 Free PMC article.
Long-Term Outcomes of Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Relapse after Definitive Radiotherapy for Prostate Cancer: Patterns of Failure and Association between Volume of Irradiation and Late Toxicity.
Miszczyk M, Kraszkiewicz M, Moll M, Kaminiów K, Sobel S, Dolla Ł, Wojcieszek P, Rajwa P, Yanagisawa T, Nowicka Z, Shariat SF, Goldner G, Miszczyk L, Majewski W. Miszczyk M, et al. Among authors: miszczyk l. Cancers (Basel). 2023 Feb 13;15(4):1180. doi: 10.3390/cancers15041180. Cancers (Basel). 2023. PMID: 36831523 Free PMC article.
73 results